Abstract P376: Clinical Use of a Proteomic Cardiovascular Risk Score for Assessing How Personal Risk Assessment Positively Drives Patient Attitudes and Behavior Change

Abstract

Background: The ACC has outlined a strategic goal where innovation and knowledge optimize cardiovascular care and outcomes. We tested whether sharing with patients a personal 7-protein cardiovascular risk score might motivate them to better adhere to cardiovascular risk reduction measures. Methods: The 7-protein risk score (SOMAscan® CVD Secondary Risk Panel, SomaLogic) provides % risk by year for experiencing a cardiovascular event up to 5 years. Patients with stable coronary heart disease received a baseline lifestyle and behavior survey, chart abstraction, and blood draw for the 7-protein risk score. Results were shared with the patient by their physician. One month after receiving the panel results, patients were surveyed on the overall impact of the panel on health, lifestyle, and medication changes. Results: Among the 138 patients, 23.9% had ≥ 20% predicted risk of a cardiovascular event in 5 years. Higher risk patients reported higher rates of desirable lifestyle changes, including healthier diet (Figure 1). Lower risk patients stated they would maintain their lifestyle to remain healthy. Conclusions: Patients presented with their personal 7-protein cardiovascular risk score were motivated to improve their lifestyle and adherence to medications. The additional motivation from the test results, if sustained long-term, may translate into improved outcomes in patients with coronary heart disease.